查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1747898

全球放射性示蹤劑市場

Radioactive Tracers
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 249 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球放射性示蹤劑市場規模將達到 56 億美元

全球放射性示蹤劑市場規模預計在2024年達到37億美元，預計2024年至2030年期間的複合年成長率為7.0%，到2030年將達到56億美元。診斷用放射性示蹤劑是本報告分析的細分市場之一，預計其複合年成長率為8.0%，到分析期結束時市場規模將達到37億美元。治療用放射性示蹤劑細分市場在分析期間內的複合年成長率預計為4.8%。

美國市場規模估計為 9.848 億美元；中國市場預期複合年成長率為 6.7%

美國放射性示蹤劑市場規模預計2024年達到9.848億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到8.978億美元，在2024-2030年的分析期內，複合年成長率為6.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為6.6%和5.8%。在歐洲，預計德國市場的複合年成長率為5.5%。

全球「放射性示蹤劑」市場—主要趨勢與促進因素摘要

放射性示蹤劑是否是支持精準診斷和工業發現的無名英雄？

放射性示蹤劑已從一種小眾的科學工具轉變為醫療和工業領域不可或缺的資產。在醫療保健領域，這些同位素化合物在核子醫學中至關重要，它們用於透過PET（正子斷層掃描）和SPECT（單光子發射電腦斷層掃描）等成像方式即時可視化生理過程。這種能力可以早期發現癌症、心血管疾病和神經系統疾病等疾病，顯著改善治療效果。除了醫療保健之外，放射性示蹤劑在工業應用中也發揮著至關重要的作用，例如管道洩漏檢測、地下水流測繪以及複雜製造過程中的化學反應監測。它們能夠以極高的精度追蹤微量物質，這使得它們在對精度要求極高的環境中備受重視。監管機構和學術機構持續擴大對半衰期更短、安全性更高的新型同位素的研究，以實現更廣泛的應用。放射性示蹤劑以其微創性和極強的洞察力，徹底改變了生物和物理科學中資料收集的方式，並牢固地鞏固了其在現代創新中的價值。

為什麼同位素生產的進步會改變示踪劑的模式？

同位素生產技術的進步顯著改善了圍繞放射性示蹤劑的整個生態系統。傳統上依賴核子反應爐的示踪同位素生產正日益得到高功率迴旋加速器和直線加速器的補充。這些設施可以根據需要在局部生產廣泛用於 PET 和 SPECT 診斷的同位素，例如氟-18、Technetium-99m 和鎵-68。同位素生產的分散化減少了對國際核子反應爐設施的依賴，最大限度地減少了運輸過程中的物流瓶頸和同位素崩壞。此外，新的放射化學技術提高了示蹤劑的產量、純度和穩定性，並增強了影像性能和病患安全性。放射性藥物合成的自動化使醫院和影像中心能夠內部配製劑量，縮短了治療時間，並可以根據特定的臨床需求定製配方。在工業環境中，放射性同位素示蹤材料經過精心設計，在惡劣環境下具有更高的耐用性和精度。這些突破不僅最佳化了現有的應用，也將示蹤劑的使用擴展到個人化醫療、農業化學品研究、先進材料分析等新領域。隨著生產技術的日益成熟，示蹤劑使用的可及性、效率和創新性正在提升到新的高度。

不斷擴大的臨床和工業應用能否維持長期的市場發展動能？

放射性示蹤劑的應用比以往任何時候都更加多樣化，這對於維持長期的市場發展動能至關重要。在臨床應用中，鎦不僅對診斷至關重要，而且對治療診斷應用也至關重要，治療診斷是指使用同一種放射性標記物將影像診斷與標靶治療相結合。例如，鎦-177因其同時具有診斷潛力而在前列腺癌和神經內分泌腫瘤的治療中備受關注。在心臟病學領域，銣-82等示蹤劑可以增強心肌灌注的即時評估。在工業領域，示蹤劑擴大用於環境監測，以研究土壤侵蝕、沉積物輸送和污染物擴散。在石油和天然氣領域，示踪劑被用於儲存表徵和提高採收率過程。此外，食品和農業研究人員正在利用示蹤劑評估作物的養分吸收並監測農藥的吸收。示蹤劑在藥物開發中的效用，尤其是在藥物動力學和生物分佈研究中，是另一個快速發展的領域。隨著各領域對精度的要求日益提高，放射性同位素固有的可追溯性使其成為無與倫比的工具。終端用途的擴展不僅創造了持續的需求，也刺激了多學科創新，而示踪技術在其中發揮核心作用。

是什麼推動了放射性示蹤劑市場的持續成長？

放射性示踪劑市場的成長受到多種因素的驅動，這些因素與技術進步、終端應用的拓展以及業務效率的提高有關。從技術角度來看，同位素合成、微型迴旋加速器開發以及自動化放射性標記系統的創新顯著提高了示蹤劑的可得性、一致性和安全性。在醫療保健領域，慢性疾病（尤其是癌症和心血管疾病）的發生率不斷上升，推動了對放射性追蹤劑獨特提供的早期診斷工具的需求。示蹤劑與PET/CT和PET/MRI等混合影像系統的整合，進一步推動了其在精準醫療中的應用。在工業領域，對永續實踐和高效資源管理的追求，使得示蹤劑在流量分析、洩漏檢測和製程最佳化方面發揮了重要作用。政府和私人機構對核子醫學的資金投入不斷增加，以及對放射性藥物研發的投資不斷增加，正在推動商業規模的技術創新。消費行為趨勢也在發揮作用，因為日益增強的健康意識正在推動非侵入性診斷程序的採用。此外，監管機構的支持，例如加速核准和全球安全標準的協調，也使新型示蹤劑製劑能夠順利進入市場。這些市場促進因素共同推動了全球放射性示蹤劑市場在臨床和工業領域的強勁擴張。

部分

類型（診斷放射性追蹤劑、治療放射性追蹤劑、其他類型）、應用（腫瘤學、心臟病學、神經病學、甲狀腺、整形外科、內分泌學、其他應用）、最終用戶（醫院、專科診所、診斷中心、學術和研究機構、其他最終用戶）

受訪公司範例（總合48家公司）

  • ABX Advanced Biochemical Compounds
  • Advanced Accelerator Applications
  • Bayer AG
  • Blue Earth Diagnostics
  • Bracco Imaging
  • Cardinal Health
  • Curium
  • DuChemBio Co., Ltd.
  • Eckert & Ziegler
  • GE HealthCare
  • IBA Radiopharma Solutions
  • Invicro LLC
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • Mallinckrodt Nuclear Medicine LLC
  • Nordion（Canada）Inc.
  • NorthStar Medical Radioisotopes LLC
  • NTP Radioisotopes
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP35635

Global Radioactive Tracers Market to Reach US$5.6 Billion by 2030

The global market for Radioactive Tracers estimated at US$3.7 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Diagnostic Radioactive Tracers, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Therapeutic Radioactive Tracers segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$984.8 Million While China is Forecast to Grow at 6.7% CAGR

The Radioactive Tracers market in the U.S. is estimated at US$984.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$897.8 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global "Radioactive Tracers" Market - Key Trends & Drivers Summarized

Are Radioactive Tracers The Invisible Heroes Powering Precision Diagnostics And Industrial Discovery?

Radioactive tracers have transformed from a niche scientific tool to an indispensable asset across both the medical and industrial sectors. In healthcare, these isotopic compounds are pivotal in nuclear medicine, where they are used to visualize physiological processes in real time through imaging modalities like PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography). This capability enables early detection of diseases such as cancer, cardiovascular disorders, and neurological conditions, improving treatment outcomes significantly. Beyond medicine, radioactive tracers play a critical role in industrial applications like leak detection in pipelines, mapping underground water flows, and monitoring chemical reactions in complex manufacturing processes. Their ability to track minute quantities of substances with exceptional accuracy makes them invaluable in environments where precision is non-negotiable. Regulatory agencies and academic institutions continue to expand research into newer isotopes with lower half-lives and improved safety profiles, making them more viable for broader applications. With minimal invasiveness and maximum insight, radioactive tracers are revolutionizing how data is gathered in the biological and physical sciences alike, anchoring their value firmly in modern innovation.

Why Are Advancements In Isotope Production Reshaping The Tracer Landscape?

The entire ecosystem surrounding radioactive tracers has been significantly elevated by advancements in isotope production technologies. Traditionally reliant on nuclear reactors, tracer isotope production is increasingly being supplemented by high-output cyclotrons and linear accelerators. These facilities allow for localized, on-demand generation of isotopes such as fluorine-18, technetium-99m, and gallium-68, which are widely used in PET and SPECT diagnostics. The decentralization of isotope production has reduced dependency on international reactor facilities, minimizing logistical bottlenecks and isotope decay during transit. Additionally, new radiochemistry techniques have improved the yield, purity, and stability of tracers, enhancing both their imaging performance and patient safety. Automation in radiopharmaceutical synthesis is allowing hospitals and imaging centers to prepare doses in-house, reducing time to treatment and customizing formulations based on specific clinical needs. In industrial settings, radioisotope tracing materials are being engineered for greater durability and precision in harsh environments. These breakthroughs are not only optimizing current applications but also expanding tracer use into emerging areas such as personalized medicine, agrochemical research, and advanced material analysis. As production technologies grow more sophisticated, accessibility, efficiency, and innovation in tracer use are scaling to new heights.

Can Expanding Clinical And Industrial Applications Sustain Long-Term Market Momentum?

Radioactive tracers are experiencing unprecedented diversification in their applications, which is instrumental in sustaining long-term market momentum. In clinical environments, they are now integral not only for diagnosis but also for theranostic applications-where diagnostic imaging and targeted therapy converge using the same radiolabeled agent. For instance, lutetium-177 is gaining ground in treating prostate cancer and neuroendocrine tumors with simultaneous diagnostic capability. In cardiology, tracers like rubidium-82 are enhancing real-time assessment of myocardial perfusion. Industrially, tracers are increasingly being utilized in environmental monitoring to study soil erosion, sediment transport, and pollutant dispersion. The oil and gas sector uses them for reservoir characterization and enhanced recovery processes. Moreover, food and agriculture researchers deploy radioactive tracers to evaluate nutrient uptake in crops and monitor pesticide absorption. The utility of tracers in drug development-especially in pharmacokinetics and biodistribution studies-is another burgeoning area. As precision requirements rise across disciplines, the inherently traceable nature of radioisotopes positions them as unmatched tools. This expansion of end-uses is not only generating consistent demand but also fostering interdisciplinary innovation where tracer technology plays a central role.

What’s Fueling The Relentless Growth In The Radioactive Tracers Market?

The growth in the radioactive tracers market is driven by several factors related to technological evolution, end-use expansion, and operational efficiency. Technologically, innovations in isotope synthesis, miniaturized cyclotron development, and automated radiolabeling systems have significantly enhanced tracer availability, consistency, and safety. In healthcare, the rising incidence of chronic diseases-particularly cancer and cardiovascular disorders-has escalated demand for early diagnostic tools that radioactive tracers uniquely provide. The integration of tracers into hybrid imaging systems like PET/CT and PET/MRI is further boosting their adoption in precision medicine. In industrial domains, the push for sustainable practices and efficient resource management has made tracers invaluable in flow analysis, leak detection, and process optimization. Increased funding in nuclear medicine by governments and private institutions, along with growing investments in radiopharmaceutical R&D, are propelling commercial-scale innovation. Consumer behavior trends also play a part, as rising health awareness encourages uptake of non-invasive diagnostic procedures. Additionally, regulatory support in terms of expedited approvals and global harmonization of safety standards is enabling smoother market entry for new tracer formulations. Collectively, these drivers are shaping a robust and expanding global market for radioactive tracers across both clinical and industrial verticals.

SCOPE OF STUDY:

The report analyzes the Radioactive Tracers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Other Types); Application (Oncology, Cardiology, Neurology, Thyroid, Orthopedic, Endocrinology, Other Applications); End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • ABX Advanced Biochemical Compounds
  • Advanced Accelerator Applications
  • Bayer AG
  • Blue Earth Diagnostics
  • Bracco Imaging
  • Cardinal Health
  • Curium
  • DuChemBio Co., Ltd.
  • Eckert & Ziegler
  • GE HealthCare
  • IBA Radiopharma Solutions
  • Invicro LLC
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • Mallinckrodt Nuclear Medicine LLC
  • Nordion (Canada) Inc.
  • NorthStar Medical Radioisotopes LLC
  • NTP Radioisotopes
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Radioactive Tracers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer and Chronic Diseases Drives Clinical Adoption of Radioactive Tracers
    • Technological Advances in PET and SPECT Imaging Strengthen Demand for Precision Tracers
    • Expansion of Nuclear Medicine Infrastructure Globally Sustains Supply and Demand Growth
    • Government Support for Diagnostic Imaging and Radiopharmaceutical R&D Spurs Innovation
    • Growing Use of Tracers in Personalized Medicine and Targeted Therapy Expands Clinical Relevance
    • Aging Population and Early Diagnosis Trends Accelerate Use of Diagnostic Tracers
    • Supply Chain Constraints and Short Half-Life of Isotopes Present Logistical Challenges
    • Partnerships Between Hospitals and Radiopharmacies Strengthen Distribution Models
    • Rising Research in Neurology and Cardiology Imaging Drives Diversification of Tracer Applications
    • Increasing Regulatory Approvals for Novel Tracers Expand the Therapeutic Toolbox
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Radioactive Tracers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Diagnostic Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Therapeutic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Therapeutic Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Thyroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Radioactive Tracers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of World 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of World 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION